Post-approval studies (Phase 4)UnknownNCT02821689
What this trial is testing
Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
Who this might be right for
DermatopolymyositisInterstitial Lung Disease
RenJi Hospital 57